Skip to main content
Tech.euFundingExplorerBeta

SR One

Investor profile

SR One has backed 5 European tech companies across 5 funding rounds between 2015 and 2025, joining rounds totalling €247M. Most active in Healthtech and AI. Data as of Nov 2026.

Deals
5
distinct rounds
Companies
5
backed
Active span
2015–2025
11 yrs
Total round €
€247M
sum of rounds joined

Deals by year

distinct rounds / year
SR One — deals by year — interactive chart.
Data table
SR One — deals by year
20151
20171
20241
20252

Top sectors

by deals
SR One — top sectors — interactive chart.
Data table
SR One — top sectors
Healthtech4
AI1

Stages

by deals
SR One — stages — interactive chart.
Data table
SR One — stages
Series B3
Other1
Series A1

Countries

by deals
SR One — countries — interactive chart.
Data table
SR One — countries
UK3
Denmark1
Switzerland1

Co-investment network

shared rounds
Co-investment network — interactive chart.
SR One — 5 dealsSR OneF-Prime Capital — 2 shared deals · click to openF-Prime CapitalVersant Ventures — 2 shared deals · click to openVersant VenturesAbingworth LLP — 1 shared deals · click to openAbingworth LLPBayer Global Investments — 1 shared deals · click to openBayer Global InvestmentsCelgene — 1 shared deals · click to openCelgeneDawn Biopharma — 1 shared deals · click to openDawn BiopharmaExport and Investment Fund of Denmark (EIFO) — 1 shared deals · click to openExport and Investment Fund of Denmark (EIFO)GlaxoSmithKline — 1 shared deals · click to openGlaxoSmithKlineIP Group — 1 shared deals · click to openIP GroupJohnson & Johnson — 1 shared deals · click to openJohnson & JohnsonJohnson & Johnson Innovation — 1 shared deals · click to openJohnson & Johnson InnovationKhosla Ventures — 1 shared deals · click to openKhosla VenturesLongview Ventures — 1 shared deals · click to openLongview VenturesNew Enterprise Associates — 1 shared deals · click to openNew Enterprise AssociatesNew Enterprise Associates (NEA) — 1 shared deals · click to openNew Enterprise Associates (NEA)Novo Holdings — 1 shared deals · click to openNovo HoldingsNvidia — 1 shared deals · click to openNvidiaOrbiMed — 1 shared deals · click to openOrbiMed

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Antag TherapeuticsDenmark1€80M
Charm TherapeuticsUK1€69M
CRISPR TherapeuticsSwitzerland1€59M
PulmocideUK1€28M
MISSION TherapeuticsUK1€11M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Antag TherapeuticsSeries A€80M2024-12
Charm TherapeuticsSeries B€69M2025-09
CRISPR TherapeuticsSeries B€59M2015-04
PulmocideSeries B€28M2017-03
MISSION TherapeuticsOther€11M2025-10
← Back to investors